skip to main content
Idioma:
Primo Advanced Search
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search prefilters
Busca Simples
Resultados 1 2 3 4 5 next page
Mostrar Somente
Refinado por: assunto: Aged remover assunto: Male remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
CD52 Expression in Mantle Cell Lymphoma
CD52 Expression in Mantle Cell Lymphoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

CD52 Expression in Mantle Cell Lymphoma

Bass, Adam J. ; Gong, Jerald ; Nelson, Ramona ; Rizzieri, David A.

Leukemia & lymphoma, 2002, Vol.43 (2), p.339-342 [Periódico revisado por pares]

United States: Informa UK Ltd

Texto completo disponível

Citações Citado por
2
Elacytarabine has single-agent activity in patients with advanced acute myeloid leukaemia
Elacytarabine has single-agent activity in patients with advanced acute myeloid leukaemia
Material Type:
Artigo 		Adicionar ao Meu Espaço

Elacytarabine has single-agent activity in patients with advanced acute myeloid leukaemia

O'Brien, Susan ; Rizzieri, David A. ; Vey, Norbert ; Ravandi, Farhad ; Krug, Utz O. ; Sekeres, Mikkael A. ; Dennis, Mike ; Venditti, Adriano ; Berry, Donald A. ; Jacobsen, Tove Flem ; Staudacher, Karin ; Bergeland, Trygve ; Giles, Francis J.

British journal of haematology, 2012-09, Vol.158 (5), p.581-588 [Periódico revisado por pares]

Oxford: Blackwell Publishing Ltd

Texto completo disponível

Citações Citado por
3
Outcomes of patients who undergo aggressive induction therapy for secondary acute myeloid leukemia
Outcomes of patients who undergo aggressive induction therapy for secondary acute myeloid leukemia
Material Type:
Artigo 		Adicionar ao Meu Espaço

Outcomes of patients who undergo aggressive induction therapy for secondary acute myeloid leukemia

Rizzieri, David A. ; O'Brien, Jenny A. ; Broadwater, Gloria ; Decastro, Carlos M. ; Dev, Prakash ; Diehl, Louis ; Beaven, Anne ; Lagoo, Anand ; Gockerman, Jon P. ; Chao, Nelson J. ; Moore, Joseph O.

Cancer, 2009-07, Vol.115 (13), p.2922-2929 [Periódico revisado por pares]

Hoboken: Wiley Subscription Services, Inc., A Wiley Company

Texto completo disponível

Citações Citado por
4
Phase I evaluation of gemcitabine, mitoxantrone, and their effect on plasma disposition of fludarabine in patients with relapsed or refractory acute myeloid leukemia
Phase I evaluation of gemcitabine, mitoxantrone, and their effect on plasma disposition of fludarabine in patients with relapsed or refractory acute myeloid leukemia
Material Type:
Artigo 		Adicionar ao Meu Espaço

Phase I evaluation of gemcitabine, mitoxantrone, and their effect on plasma disposition of fludarabine in patients with relapsed or refractory acute myeloid leukemia

Rao, Arati V. ; Younis, Islam R. ; Sand, Gregory J. ; Spasojevic, Ivan ; Adams, David J. ; Decastro, Carlos M. ; Gockerman, John P. ; Peterson, Bercedis L. ; Petros, William P. ; Moore, Joseph O. ; Rizzieri, David A.

Leukemia & lymphoma, 2008-01, Vol.49 (8), p.1523-1529 [Periódico revisado por pares]

United States: Informa UK Ltd

Texto completo disponível

Citações Citado por
5
The DOT1L inhibitor pinometostat reduces H3K79 methylation and has modest clinical activity in adult acute leukemia
The DOT1L inhibitor pinometostat reduces H3K79 methylation and has modest clinical activity in adult acute leukemia
Material Type:
Artigo 		Adicionar ao Meu Espaço

The DOT1L inhibitor pinometostat reduces H3K79 methylation and has modest clinical activity in adult acute leukemia

Stein, Eytan M. ; Garcia-Manero, Guillermo ; Rizzieri, David A. ; Tibes, Raoul ; Berdeja, Jesus G. ; Savona, Michael R. ; Jongen-Lavrenic, Mojca ; Altman, Jessica K. ; Thomson, Blythe ; Blakemore, Stephen J. ; Daigle, Scott R. ; Waters, Nigel J. ; Suttle, A. Benjamin ; Clawson, Alicia ; Pollock, Roy ; Krivtsov, Andrei ; Armstrong, Scott A. ; DiMartino, Jorge ; Hedrick, Eric ; Löwenberg, Bob ; Tallman, Martin S.

Blood, 2018-06, Vol.131 (24), p.2661-2669 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
6
Tagraxofusp in Blastic Plasmacytoid Dendritic-Cell Neoplasm
Tagraxofusp in Blastic Plasmacytoid Dendritic-Cell Neoplasm
Material Type:
Artigo 		Adicionar ao Meu Espaço

Tagraxofusp in Blastic Plasmacytoid Dendritic-Cell Neoplasm

Pemmaraju, Naveen ; Lane, Andrew A ; Sweet, Kendra L ; Stein, Anthony S ; Vasu, Sumithira ; Blum, William ; Rizzieri, David A ; Wang, Eunice S ; Duvic, Madeleine ; Sloan, J. Mark ; Spence, Sharon ; Shemesh, Shay ; Brooks, Christopher L ; Balser, John ; Bergstein, Ivan ; Lancet, Jeffrey E ; Kantarjian, Hagop M ; Konopleva, Marina

The New England journal of medicine, 2019-04, Vol.380 (17), p.1628-1637 [Periódico revisado por pares]

United States: Massachusetts Medical Society

Texto completo disponível

Citações Citado por
7
Prognostic factors for outcomes in allogeneic transplantation for CML in the imatinib era: a CIBMTR analysis
Prognostic factors for outcomes in allogeneic transplantation for CML in the imatinib era: a CIBMTR analysis
Material Type:
Artigo 		Adicionar ao Meu Espaço

Prognostic factors for outcomes in allogeneic transplantation for CML in the imatinib era: a CIBMTR analysis

KHOURY, H. J ; KUKREJA, M ; GALE, R. P ; MARKS, D. I ; MCCARTHY, P. L ; WOOLFREY, A ; SZER, J ; GIRALT, S. A ; MAZIARZ, R. T ; CORTES, J ; HOROWITZ, M. M ; LEE, S. J ; GOLDMAN, J. M ; WANG, T ; HALTER, J ; ARORA, M ; GUPTA, V ; RIZZIERI, D. A ; GEORGE, B ; KEATING, A

Bone marrow transplantation (Basingstoke), 2012-06, Vol.47 (6), p.810-816 [Periódico revisado por pares]

Basingstoke: Nature Publishing Group

Texto completo disponível

Citações Citado por
8
Disabling Immune Tolerance by Programmed Death-1 Blockade With Pidilizumab After Autologous Hematopoietic Stem-Cell Transplantation for Diffuse Large B-Cell Lymphoma: Results of an International Phase II Trial
Disabling Immune Tolerance by Programmed Death-1 Blockade With Pidilizumab After Autologous Hematopoietic Stem-Cell Transplantation for Diffuse Large B-Cell Lymphoma: Results of an International Phase II Trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Disabling Immune Tolerance by Programmed Death-1 Blockade With Pidilizumab After Autologous Hematopoietic Stem-Cell Transplantation for Diffuse Large B-Cell Lymphoma: Results of an International Phase II Trial

ARMAND, Philippe ; NAGLER, Arnon ; FAY, Joseph W ; RIZZIERI, David A ; HOSING, Chitra M ; BALL, Edward D ; UBERTI, Joseph P ; LAZARUS, Hillard M ; MAPARA, Markus Y ; GREGORY, Stephanie A ; TIMMERMAN, John M ; ANDORSKY, David ; WELLER, Edie A ; OR, Reuven ; WALLER, Edmund K ; ROTEM-YEHUDAR, Rinat ; GORDON, Leo I ; DEVINE, Steven M ; AVIGAN, David E ; CHEN, Yi-Bin ; KAMINSKI, Mark S ; KENT HOLLAND, H ; WINTER, Jane N ; MASON, James R

Journal of clinical oncology, 2013-11, Vol.31 (33), p.4199-4206 [Periódico revisado por pares]

Alexandria, VA: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
9
A Phase 2 Clinical Trial of Deforolimus (AP23573, MK-8669), a Novel Mammalian Target of Rapamycin Inhibitor, in Patients with Relapsed or Refractory Hematologic Malignancies
A Phase 2 Clinical Trial of Deforolimus (AP23573, MK-8669), a Novel Mammalian Target of Rapamycin Inhibitor, in Patients with Relapsed or Refractory Hematologic Malignancies
Material Type:
Artigo 		Adicionar ao Meu Espaço

A Phase 2 Clinical Trial of Deforolimus (AP23573, MK-8669), a Novel Mammalian Target of Rapamycin Inhibitor, in Patients with Relapsed or Refractory Hematologic Malignancies

Rizzieri, David A ; Feldman, Eric ; Dipersio, John F ; Gabrail, Nashat ; Stock, Wendy ; Strair, Roger ; Rivera, Victor M ; Albitar, Maher ; Bedrosian, Camille L ; Giles, Francis J

Clinical cancer research, 2008-05, Vol.14 (9), p.2756-2762 [Periódico revisado por pares]

United States: American Association for Cancer Research

Texto completo disponível

Citações Citado por
10
Safety and tolerability of guadecitabine (SGI-110) in patients with myelodysplastic syndrome and acute myeloid leukaemia: a multicentre, randomised, dose-escalation phase 1 study
Safety and tolerability of guadecitabine (SGI-110) in patients with myelodysplastic syndrome and acute myeloid leukaemia: a multicentre, randomised, dose-escalation phase 1 study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Safety and tolerability of guadecitabine (SGI-110) in patients with myelodysplastic syndrome and acute myeloid leukaemia: a multicentre, randomised, dose-escalation phase 1 study

Issa, Jean-Pierre J, Prof ; Roboz, Gail, Prof ; Rizzieri, David, Prof ; Jabbour, Elias, MD ; Stock, Wendy, Prof ; O'Connell, Casey, MD ; Yee, Karen, MD ; Tibes, Raoul, MD ; Griffiths, Elizabeth A, MD ; Walsh, Katherine, MD ; Daver, Naval, MD ; Chung, Woonbok, PhD ; Naim, Sue, BS ; Taverna, Pietro, PhD ; Oganesian, Aram, PhD ; Hao, Yong, MD ; Lowder, James N, MD ; Azab, Mohammad, MD ; Kantarjian, Hagop, Prof

The lancet oncology, 2015-09, Vol.16 (9), p.1099-1110 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (395)

Data de Publicação 

De até
Refinar
  1. Antes de2003  (11)
  2. 2003Até2007  (47)
  3. 2008Até2012  (129)
  4. 2013Até2018  (198)
  5. Após 2018  (48)
  6. Mais opções open sub menu

Idioma 

  1. Inglês  (430)
  2. Japonês  (68)
  3. Português  (3)
  4. Russo  (1)
  5. Francês  (1)
  6. Espanhol  (1)
  7. Norueguês  (1)
  8. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.